Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AMLX
ATRC
Add up to 3 more stocks
AMLX
Amylyx Pharmaceuticals, Inc.
-0.63%
$27.60-0.18Delayed quote: Oct 6, 2026, 12:15 PM EDT
Market Cap
$3.07B
52W Range
$10.83 - $41.14
ATRC
AtriCure, Inc.
-2.29%
$55.08-1.29Delayed quote: Oct 6, 2026, 12:15 PM EDT
Market Cap
$2.80B
52W Range
$25.36 - $61.70
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 259.57 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 12.83 | 5.43 |
| P/S Ratio | N/A | 4.92 |
| P/FCF Ratio | N/A | 54.60 |
| EV/EBITDA | N/A | 77.85 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 76.2% |
| Operating Margin | 0.0% | 2.4% |
| Net Margin | 0.0% | 1.9% |
| ROE | -63.6% | 2.0% |
| ROA | -57.5% | 1.6% |
| ROIC | -66.6% | 2.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.12 | 4.22 |
| Quick Ratio | 12.12 | 3.19 |
| Debt/Equity | 0.02 | 0.14 |
| Interest Coverage | N/A | -0.59 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.